Acceptance rate 46%
Time to first decision 6 months*
Time to decision with review 50 days*

*Approximate number of days

**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.


ACTA Pharmaceutica Sciencia 2021 , Vol 59 , Num 3
Stability Indicating Method Development and Validation of Ranolazine Extended Release Tablets
Evin Aycicek DURAK 1 İbrahim KURTGÖZ 2 Burcu MESUT 1 Erdal CEVHER 1 Yıldız ÖZSOY 1
1 Istanbul University, Faculty of Pharmacy, Pharmaceutical Technology Dept., Beyazıt, Istanbul, Turkey, 2 Biopharma Pharmaceutical, Istanbul, Turkey DOI : 10.23893/1307-2080.APS.05925

Summary

Istanbul Medipol University